scholarly journals Don't forget reversible posterior leukoencephalopathy syndrome (RPLS) / posterior reversible encephalopathy syndrome (PRES)

2008 ◽  
Vol 15 (4) ◽  
pp. 480-484 ◽  
Author(s):  
Yasuhiro Ito ◽  
Makoto Kawai ◽  
Takeshi Yasuda
Keyword(s):  
Posterior Reversible Encephalopathy Syndrome ◽  
Reversible Posterior Leukoencephalopathy Syndrome ◽  
Posterior Reversible Encephalopathy ◽  
Reversible Posterior Leukoencephalopathy ◽  
Posterior Leukoencephalopathy ◽  
Reversible Encephalopathy

scholarly journals Atypical Posterior Reversible Encephalopathy Syndrome in a Postpartum Woman With Moyamoya Disease: A Case Report and Literature Review

2021 ◽  
Vol 12 ◽  
Author(s):  
Ning Zou ◽  
Guixiang Guo ◽  
Fangchao Wan ◽  
Xin Li
Keyword(s):  
Glasgow Coma Scale ◽  
Moyamoya Disease ◽  
Posterior Reversible Encephalopathy Syndrome ◽  
Reversible Posterior Leukoencephalopathy Syndrome ◽  
Postpartum Woman ◽  
Posterior Reversible Encephalopathy ◽  
Coma Scale ◽  
Posterior Leukoencephalopathy ◽  
Collateral Vessels ◽  
Reversible Encephalopathy

Background: Moyamoya disease is a rare cerebrovascular occlusive disease, which is characterized by stenosis and gradual occlusion of the internal carotid arteries, causing the progression of characteristic collateral vessels. To date, most studies investigating moyamoya disease have focused on medical implications, and the potential implications for neurocognitive and/or neuropsychiatric functioning were inconclusive.Case Presentation: we present a case of a 26-year-old Chinese postpartum woman who presented to the emergency department with a 19-h history of cognitive decline, vomiting, and convulsions. Blood pressure, heart rate, and respiration rate were 200/120 mmHg, 115 beats/minute, and 30 breaths/minute, respectively, on arrival. The Glasgow Coma Scale, modified RANKIN scale (mRS), and National Institute of Health stroke scale (NIHSS) scores were 3, 5, and 18, respectively. Moyamoya disease was diagnosed using cerebral angiography and digital subtraction angiography. The cognitive functions of orientation, use of language, ability to calculate, and memory significantly improved after 11 days of treatment (Glasgow Coma Scale: 15; mRS: 0; NIHSS: 0).Conclusions:This patient was diagnosed with reversible posterior leukoencephalopathy syndrome related to moyamoya disease. This case highlights that atypical posterior reversible encephalopathy syndrome can occur in patients with moyamoya disease, and should be considered for the differential diagnosis of cerebral infarcts and hemorrhage in a postpartum female.

scholarly journals Síndrome da Encefalopatia Posterior Reversível (PRES) no ciclo gravídico puerperal: revisão bibliográfica

2020 ◽  
Vol 12 (11) ◽  
pp. e4724
Author(s):  
Márcia Cristina Taveira Pucci Green ◽  
Felipe Pimenta Rodrigues ◽  
Karina Martins Milaré
Keyword(s):  
Posterior Reversible Encephalopathy Syndrome ◽  
Posterior Reversible Encephalopathy ◽  
Posterior Leukoencephalopathy ◽  
Reversible Encephalopathy

Objetivo: Elencar as principais características fisiopatológicas, clínicas, diagnósticas e manejo terapêutico da Síndrome da Encefalopatia Posterior Reversível (PRES) em gestantes e puérperas. Métodos: Esta revisão da literatura usou a base de dados de pesquisa CAPES, com os descritores: “PRES”, “Posterior Reversible Encephalopathy Syndrome”, “Posterior Leukoencephalopathy Syndrome” e “Pregnancy”, entre os anos de 2003 a 2019, resultando em 50 artigos que preencheram os critérios de inclusão. Resultados: Verificou-se que, os mecanismos fisiopatológicos que buscam explicar a ocorrência geral dessa síndrome, ainda não são claros. Os principais sinais clínicos identificados foram convulsões associadas a cefaleia e alterações visuais. O exame padrão-ouro é a ressonância magnética, preferencialmente em T1, T2, ADC e DWI, estando a restrição de difusão relacionada a um pior prognóstico. Feito o diagnóstico, é necessário o manejo terapêutico com estabilização da paciente, controles pressórico, controle de convulsões e afastar a causa base que desencadeou o processo da PRES. Considerações finais: A PRES é uma síndrome de início agudo, sendo importante o reconhecimento das suas características clínicas e diagnósticas. Por isso quando pensar em PRES? Sugerimos um recurso mnemônico para lembrar como diagnóstico diferencial. P: Pré-eclâmpsia e eclâmpsia; R: Restrição de difusão na Ressonância Magnética; E: Edema cerebral; S: Sintomas visuais.

scholarly journals Reversible posterior leukoencephalopathy syndrome and anti-neoplastic agents: a review

2011 ◽  
pp. 152-161
Author(s):  
Farheen M. Shah-Khan ◽  
Daryl Pinedo ◽  
Prabodh Shah
Keyword(s):  
English Language ◽  
Early Recognition ◽  
Reversible Posterior Leukoencephalopathy Syndrome ◽  
Chemotherapeutic Agents ◽  
Reversible Posterior Leukoencephalopathy ◽  
Posterior Leukoencephalopathy ◽  
Pubmed Database ◽  
Reversible Encephalopathy ◽  
Benign Course ◽  
Rapid Presentation

Reversible Posterior Leukoencephalopathy Syndrome (RPLS) is a well recognized entity with a variety of benign and malignant conditions. Recently it has been found to be associated with the use of anti-neoplastic agents including targeted therapies. RPLS occurs rapidly with the use of some drugs and more slowly with others. Combined therapies are associated with a more frequent and more rapid presentation. This review was based on a literature search for English Language articles concerning RPLS and chemotherapeutic agents published from June 1996 to March 2007. We used the PubMed database with keywords: “RPLS”, “Posterior reversible encephalopathy syndrome”, “(PRES)”, “Chemotherapy” and “MRI”. This syndrome has classical Clinical-Radiologic features that are easy to recognize. Early recognition and withdrawal of the offending agent is all that is needed in most cases. This review highlights the features of the syndrome. It draws our attention to an entity which is being more frequently recognized and whose exact pathologic mechanisms need to be further studied. This syndrome is associated with the use of neurotoxic as well as non-neurotoxic agents and usually runs a benign course if there is an early diagnosis and management.

scholarly journals Posterior Reversible Encephalopathy Syndrome Secondary to CSF Leak and Intracranial Hypotension: A Case Report and Literature Review

2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Tariq Hammad ◽  
Alison DeDent ◽  
Rami Algahtani ◽  
Yaseen Alastal ◽  
Lawrence Elmer ◽  
...  
Keyword(s):  
Posterior Reversible Encephalopathy Syndrome ◽  
Intracranial Hypotension ◽  
Mechanistic Model ◽  
Brain Mri ◽  
Pressure Control ◽  
Csf Leak ◽  
Dural Defect ◽  
Posterior Reversible Encephalopathy ◽  
Posterior Leukoencephalopathy ◽  
Reversible Encephalopathy

Posterior Reversible Encephalopathy Syndrome (PRES) is a clinical neuroradiological condition characterized by insidious onset of neurological symptoms associated with radiological findings indicating posterior leukoencephalopathy. PRES secondary to cerebrospinal fluid (CSF) leak leading to intracranial hypotension is not well recognized etiology of this condition. Herein, we report a case of PRES that occurred in the setting of CSF leak due to inadvertent dural puncture. Patient underwent suturing of the dural defect. Subsequently, his symptoms resolved and a repeated brain MRI showed resolution of brain lesions. The pathophysiology and mechanistic model for developing PRES in the setting of intracranial hypotension were discussed. We further highlighted the importance of tight blood pressure control in patients with CSF leak and suspected intracranial hypotension because they are more vulnerable to develop PRES with normal or slightly elevated bleed pressure values.

scholarly journals A Rare Case of Cyclophosphamide-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-GBM Vasculitis, and Review of Current Literature

2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Taha Nisar ◽  
Abdul R. Alchaki ◽  
Erin Feinstein
Keyword(s):  
Posterior Reversible Encephalopathy Syndrome ◽  
Sinus Thrombosis ◽  
Altered Mental Status ◽  
Cerebral Venous Sinus Thrombosis ◽  
Clinical Syndrome ◽  
Posterior Reversible Encephalopathy ◽  
Posterior Leukoencephalopathy ◽  
Vessel Imaging ◽  
Magnetic Resonance Imaging Mri ◽  
Reversible Encephalopathy

Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome of headache, altered mental status, and seizures with reversible mainly posterior leukoencephalopathy on neuroimaging. Precipitating factors for PRES are multifactorial and include autoregulatory failure due to changes in blood pressure, metabolic derangements, and cytotoxic medications. We report the second case of cyclophosphamide-induced PRES in a patient with anti-glomerular basement membrane (Anti-GBM) positive vasculitis. In the acute setting, PRES can be challenging to distinguish from cerebral venous sinus thrombosis or cerebral vasculitis based on clinical presentation. Neuroimaging with magnetic resonance imaging (MRI) of the brain along with a vessel imaging, can help reach the diagnosis.

Posterior Reversible Encephalopathy Syndrome

2011 ◽  
Vol 3 (9) ◽  
pp. 424-425
Author(s):  
Dr. Safiya I Shaikh ◽  
◽  
Dr. C Govindaraju Dr. C Govindaraju
Keyword(s):  
Posterior Reversible Encephalopathy Syndrome ◽  
Posterior Reversible Encephalopathy ◽  
Reversible Encephalopathy
Sign in / Sign up

Export Citation Format

Share Document